<DOC>
	<DOCNO>NCT01480934</DOCNO>
	<brief_summary>To compare development posterior capsule opacification ( PCO ) eye without history diabetes mellitus ( DM ) single-piece hydrophobic acrylic intraocular lens ( IOL ) implantation 4 year postoperatively.Diabetes mellitus would increase incidence PCO 4 year .</brief_summary>
	<brief_title>Evaluation Posterior Capsule Opacification Eyes With Diabetes Mellitus</brief_title>
	<detailed_description>There paucity available literature prospectively evaluate development PCO single-piece hydrophobic acrylic IOL implantation diabetic versus non-diabetic eye long-term basis . Therefore , study design compare degree PCO cataract surgery diabetic age-matched non-diabetic patient . This prospective , observational case control study comprise patient underwent phacoemulsification .The patient ask return postoperative follow-up visit 1 month , 1 year 4 year . digital image analyze PCO .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Capsule Opacification</mesh_term>
	<criteria>Diabetes mellitus define glycosylated haemoglobin ( Hb A1c ) level 6 % , use diabetic medication ( oral hypoglycemic agent , insulin injection diet restriction ) , physician 's diagnosis diabetes . Patients uncomplicated agerelated cataract otherwise healthy constitute control ( n=75 eye ) . patient glaucoma , high myopia ( axial length &gt; 27.0 mm ) , pseudoexfoliation , traumatic cataract , subluxate cataract , previous ocular surgery , allergy dilate drop .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Diabetes , posterior capsule opacification , case control study</keyword>
</DOC>